483
Avara Liscate Pharmaceutical Services SPAAvara Liscate Pharmaceutical Services SPA – FDA 483, Dec 6, 2022
Record Details
An FDA inspection of Avara Liscate Pharmaceutical Services S.r.l. in Liscate, Italy, a contract drug manufacturer, revealed significant deficiencies in quality control and record-keeping. The firm failed to adequately investigate product complaints, out-of-specification deviations, and ensure the effectiveness of corrective actions. Additionally, the facility lacked proper microbiological control for equipment and maintained deficient batch production records.
View Company Profile
ID · 57ade3fa-5b27-4869-9303-934d3792b63d
Other documents for Avara Liscate Pharmaceutical Services SPA
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.